Zusammenfassung
Das Kapitel beleuchtet „die Angst“ als ein Kontinuum vom normalpsychologischen und funktionalen Phänomen bis hin zum pathologischen Zustand, der in Form kategorialer Angststörungen zu einer ausgeprägten psychosozialen Beeinträchtigung der Betroffenen führt. Neben der störungsspezifischen Symptomatik, wichtigen epidemiologischen Eckdaten und den gegenwärtigen Behandlungsoptionen der Angststörungen werden vor allem die psychologischen und biologischen Grundlagen bzw. Korrelate dieser Erkrankungsgruppe sowie die Rolle von Stress als wichtigem symptomauslösenden und -aufrechterhaltenden Faktor dargestellt. Hierdurch sollen ein Überblick über das multifaktorielle Bedingungsgefüge in der Entstehung krankheitswertiger Angst ermöglicht und insbesondere die wechselseitigen Beziehungen zwischen den einzelnen Aspekten verdeutlicht werden.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5. Aufl. American Psychiatric Association, Arlington
Askew C, Field AP (2007) Vicarious learning and the development of fears in childhood. Behav Res Ther 45:2616–2627
Asmundson GJ, Fetzner MG, Deboer LB et al (2013) Let’s get physical: a contemporary review of the anxiolytic effects of exercise for anxiety and its disorders. Depress Anxiety 30:362–373
Bandelow B (1995) Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The panic and agoraphobia scale. Int Clin Psychopharmacol 10:73–81
Bandelow B, Wiltink J, Alpers GW et al. (2014) Deutsche S3-Leitlinie Behandlung von Angststörungen. www.awmf.org/leitlinien.htm
Bandelow B, Baldwin D, Abelli M et al (2016) Biological markers for anxiety disorders, OCD and PTSD – a consensus statement. Part I: Neuroimaging and genetics. World J Biol Psychiatry 17:321–365
Bastiaansen JA, Servaas MN, Marsman JB et al (2014) Filling the gap: relationship between the serotonin-transporter-linked polymorphic region and amygdala activation. Psychol Sci 25:2058–2066
Beck AT (1985) Theoretical perspectives on clinical anxiety. In: Tuma AH, Maser J (Hrsg) Anxiety and the anxiety disorders. Erlbaum, Hillsdale, S 183–196
Beck JG, Carmin CN, Henninger NJ (1998) The utility of the fear survey schedule-III: an extended replication. J Anxiety Disord 12:177–182
Behar E, DiMarco ID, Hekler EB et al (2009) Current theoretical models of generalized anxiety disorder (GAD): conceptual review and treatment implications. J Anxiety Disord 23:1011–1023
Beutel ME, Scheurich V, Knebel A et al (2013) Implementing panic-focused psychodynamic therapy into clinical practice. Can J Psychiatry 58:326–334
Bienvenu OJ, Onyike CU, Stein MB et al (2006) Agoraphobia in adults: incidence and longitudinal relationship with panic. Br J Psychiatry 188:432–438
Blaya C, Salum GA, Moorjani P et al (2010) Panic disorder and serotonergic genes (SLC6A4, HTR1A and HTR2A): association and interaction with childhood trauma and parenting. Neurosci Lett 485:11–15
Chelli B, Pini S, Abelli M et al (2008) Platelet 18 kDa translocator protein density is reduced in depressed patients with adult separation anxiety. Eur Neuropsychopharmacol 18:249–254
Clark DM, Wells A (1995) A cognitive model of social phobia. In: Heimberg RG, Liebowitz MR, Hope DA, Schneider FR (Hrsg) Social phobia: diagnosis, assessment, treatment. Guildford, New York, S 69–93
Cuijpers P, Sijbrandij M, Koole SL et al (2014) Adding psychotherapy to antidepressant medication in depression and anxiety disorders: a meta-analysis. World Psychiatry 13(1):56–67
Cyranowski JM, Shear M, Rucci P et al (2002) Adult separation anxiety: psychometric properties of a new structured clinical interview. J Psychiatr Res 36:77–86
De Cagna F, Fusar-Poli L, Damiani S et al (2019) The role of intranasal oxytocin in anxiety and depressive disorders: A systematic review of randomized controlled trials. Clin Psychopharmacol Neurosci 17:1–11
Dilling H, Mombour W, Schmidt MH et al (2015) Internationale Klassifikation psychischer Störungen: ICD-10 Kapitel V (F) klinisch-diagnostische Leitlinien, 10. Aufl. Hogrefe, Bern
Domschke K, Tidow N, Kuithan H et al (2012) Monoamine oxidase A gene DNA hypomethylation – a risk factor for panic disorder? Int J Neuropsychopharmacol 15:1217–1228
Domschke K, Tidow N, Schrempf M et al (2013) Epigenetic signature of panic disorder: a role of glutamate decarboxylase 1 (GAD1) DNA hypomethylation? Prog Neuropsychopharmacol Biol Psychiatry 46:189–196
Ehlers A, Margraf J (1989) The psychophysiological model of panic attacks. In: Emmelkamp PMG, Everaerd WTAM, Kraaimaat F, van Son MJM (Hrsg) Fresh perspectives on anxiety disorders. Swets Zeitlinger, Amsterdam, S 1
Erhardt A, Akula N, Schumacher J et al (2012) Replication and meta-analysis of TMEM132D gene variants in panic disorder. Transl Psychiatry 2:e156
Fanselow MS (2018) The role of learning in threat Imminence and defensive behaviors. Curr Opin Behav Sci 24:44–49
Farb DH, Ratner MH (2014) Targeting the modulation of neural circuitry for the treatment of anxiety disorders. Pharmacol Rev 66:1002–1032
Galvao-de Almeida A, Araujo Filho GM, Berberian Ade A et al (2013) The impacts of cognitive-behavioral therapy on the treatment of phobic disorders measured by functional neuroimaging techniques: a systematic review. Rev Bras Psiquiatr 35:279–283
Garcia R (2017) Neurobiology of fear and specific phobias. Learn Mem 16::462–471
Gottschalk MG, Domschke K (2017) Genetics of generalized anxiety disorder and related traits. Dialogues Clin Neurosci 19:159–168
Graeff FG, Zangrossi H Jr (2010) The dual role of serotonin in defense and the mode of action of antidepressants on generalized anxiety and panic disorders. Cent Nerv Syst Agents Med Chem 10:207–217
Hamm AO (2017) Spezifische Phobien. Psych up2date 3:223–236
Harro J (2018) Animals, anxiety, and anxiety disorders: how to measure anxiety in rodents and why. Behav Brain Res 352:81–93
Hayes-Skelton SA, Roemer L, Orsillo SM (2013) A randomized clinical trial comparing an acceptance-based behavior therapy to applied relaxation for generalized anxiety disorder. J Consult Clin Psychol 81:761–773
Heimberg RG, Horner KJ, Juster HR et al (1999) Psychometric properties of the liebowitz social anxiety scale. Psychol Med 29:199–212
Holzschneider K, Mulert C (2012) Neuroimaging in anxiety disorders. Dialogues Clin Neurosci 13:453–461
Howe AS, Buttenschøn HN, Bani-Fatemi A et al (2016) Candidate genes in panic disorder: meta-analyses of 23 common variants in major anxiogenic pathways. Mol Psychiatry 21:665–679
Irle E, Ruhleder M, Lange C et al (2010) Reduced amygdalar and hippocampal size in adults with generalized social phobia. J Psychiatry Neurosci 35:126–131
Jacobi F, Höfler M, Siegert J et al (2014) Twelve-month prevalence, comorbidity and correlates of mental disorders in Germany: the mental health module of the German health interview and examination survey for adults (DEGS1-MH). Int J Methods Psychiatr Res 23:304–319
Kaczkurkin AN, Foa EB (2015) Cognitive-behavioral therapy for anxiety disorders: an update on the empirical evidence. Dialogues Clin Neurosci 17:337–346
Kandel ER, Hawkins RD (1992) Molekulare Grundlagen des Lernens. Spektrum der Wissenschaft 11:66–76
Katzman MA, Bleau P, Blier P et al. (2014) Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry 14(1):S1
Keefe JR, McCarthy KS, Dinger U et al (2014) A meta-analytic review of psychodynamic therapies for anxiety disorders. Clin Psychol Rev 34:309–323
Kogan CS, Stein DJ, Maj M et al (2016) The classification of anxiety and fear-related disorders in the ICD-11. Depress Anxiety 33:1141–1154
Lahat A, Hong M, Fox NA (2011) Behavioural inhibition: is it a risk factor for anxiety? Int Rev Psychiatry 23:248–257
Lakshmi J, Sudhir PM, Sharma MP et al (2016) Effectiveness of metacognitive therapy in patients with social anxiety disorder: a pilot investigation. Indian J Psychol Med 38:466–471
Lai CH (2011) Gray matter deficits in panic disorder: a pilot study of meta-analysis. J Clin Psychopharmacol 31:287–293
Lang T, Helbig-Lang S, Westphal D et al (2012) Expositionsbasierte Therapie der Panikstörung mit Agoraphobie. Ein Behandlungsmanual. Hogrefe, Göttingen
Leichsenring F, Salzer S, Jaeger U et al (2009) Short-term psychodynamic psychotherapy and cognitive-behavioral therapy in generalized anxiety disorder: a randomized, controlled trial. Am J Psychiatry 166:875–881
Leichsenring F, Salzer S, Beutel ME et al (2013) Psychodynamic therapy and cognitive-behavioral therapy in social anxiety disorder: a multicenter randomized controlled trial. Am J Psychiatry 170:759–767
Lissek S, Powers AS, McClure EB et al (2005) Classical fear conditioning in the anxiety disorders: a meta-analysis. Behav Res Ther 43:1391–1424
Lueken U, Zierhut KC, Hahn T et al (2016) Neurobiological markers predicting treatment response in anxiety disorders: a systematic review and implications for clinical application. Neurosci Biobehav Rev 66:143–162
Maron E, Kuikka JT, Shlik J et al (2004) Reduced brain serotonin transporter binding in patients with panic disorder. Psychiatry Res 132:173–181
Maron E, Nutt D, Shlik J (2012) Neuroimaging of serotonin system in anxiety disorders. Curr Pharm Des 18:5699–5708
Merikangas KR, Swanson SA (2010) Comorbidity in anxiety disorders. Curr Top Behav Neurosci 2:37–59
Meyer TJ, Miller ML, Metzger RL et al (1990) Development and validation of the Penn State Worry Questionnaire. Behav Res Ther 28:487–495
Mowrer OH (1960) Learning theory and behavior. Wiley, New York
Nagel M, Jansen PR, Stringer S et al (2018) Meta-analysis of genome-wide association studies for neuroticism in 449,484 individuals identifies novel genetic loci and pathways. Nat Genet 50:920–927
Nash JR, Sargent PA, Rabiner EA et al (2008) Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study. Br J Psychiatry 193:229–234
Öhman A, Mineka S (2001) Fears, phobias, and preparedness: toward an evolved module of fear and fear learning. Psychol Rev 108:483–522
Öst LG, Thulin U, Ramnero J (2004) Cognitive behavior therapy vs exposure in vivo in the treatment of panic disorder with agoraphobia (corrected from agrophobia). Behav Res Ther 42:1105–1127
Offidani E, Guidi J, Tomba E et al (2013) Efficacy and tolerability of benzodiazepines versus antidepressants in anxiety disorders: a systematic review and meta-analysis. Psychother Psychosom 82:355–362
Pavlov IP (1927) Conditional reflexes: an investigation of the physiological activity of the cerebral cortex. Oxford University Press, Oxford
Perna G, Alciati A, Riva A et al (2016) Long-term pharmacological treatments of anxiety disorders: an updated systematic review. Curr Psychiatry Rep 18:23
Peterson A, Thome J, Frewen P et al (2014) Resting-state neuroimaging studies: a new way of identifying differences and similarities among the anxiety disorders? Can J Psychiatry 59(6):294–300
Phan KL, Coccaro EF, Angstadt M et al (2013) Corticolimbic brain reactivity to social signals of threat before and after sertraline treatment in generalized social phobia. Biol Psychiatry 73:329–336
Plag J, Ströhle A (2012) Pharmakotherapie der Angststörungen. In: Gründer G, Benkert O (Hrsg) Handbuch der psychiatrischen Pharmakotherapie, 2. Aufl. Springer, Heidelberg
Plag J, Hoyer J (2019) Die generalisierte Angststörung – ein update. Psych up2date 13:243–260
Plag J, Siegmund A, Ströhle A (2012) Neue Ansätze in der Angstbehandlung. In: Rupprecht R, Kellner M (Hrsg) Angststörungen. Klinik, Forschung, Therapie. Kohlhammer, Stuttgart
Plag J, Schumacher S, Schmid U et al (2013) Baseline and acute changes in the HPA system in patients with anxiety disorders: current state of research. Neuropsychiatry 3(1–18):1
Reiss S, McNally RJ (1985) Expectancy model of fear. In: Reiss S, Bootzin RR (Hrsg) Theoretical issues in behavior therapy. Academic, New York, S 107–121
Sanchez-Meca J, Rosa-Alcazar AI, Marın-Martınez F et al (2010) Psychological treatment of panic disorder with or without agoraphobia: a meta-analysis. Clin Psychol Rev 30:37–50
Schiele MA, Domschke K (2018) Epigenetics at the crossroads between genes, environment and resilience in anxiety disorders. Genes Brain Behav 17:e12423
Seligman MEP (1971) Phobias and preparedness. Behav Ther 2:307–320
Shimada-Sugimoto M, Otowa T, Hettema JM (2015) Genetics of anxiety disorders: genetic epidemiological and molecular studies in humans. Psychiatry Clin Neurosci 69:388–401
Skinner BF (1938) The behavior of organisms: an experimental analysis. Appleton-Century, Oxford
Smoller JW (2016) The genetics of stress-related disorders: PTSD, depression, and anxiety disorders. Neuropsychopharmacology 41:297–319
Spindelegger C, Lanzenberger R, Wadsak W et al (2009) Influence of escitalopram treatment on 5-HAT 1A receptor binding in limbic regions in patients with anxiety disorders. Mol Psychiatry 14:1040–1050
Stein MB, Chen CY, Jain S et al (2017) Genetic risk variants for social anxiety. Am J Med Genet B Neuropsychiatr Genet 174:120–131
Steinhausen HC (2010) Fragebogen zur Erfassung des Elektiven Mutismus (FEM). In: Steinhausen HC (Hrsg) Psychische Störungen bei Kindern und Jugendlichen, 7. Aufl. Elsevier, München, S 558–560
Ströhle A, Romeo E, di Michele F et al (2002) GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment. Am J Psychiatry 159:145–147
Ströhle A, Feller C, Strasburger CJ et al (2006) Anxiety modulation by the heart? Aerobic exercise and atrial natriuretic peptide. Psychoneuroendocrinology 31:1127–1130
Stubbs B, Vancampfort D, Rosenbaum S et al (2017) An examination of the anxiolytic effects of exercise for people with anxiety and stress-related disorders: a meta-analysis. Psychiatry Res 249:102–108
Thorndike EL (1911) Animal intelligence. Experimental studies. Macmillan, New York
van der Heiden C, Muris P, Van der Molen HT (2012) Randomized controlled trial on the effectiveness of metacognitive therapy and tolerance-of-uncertainty therapy for generalized anxiety disorder. Behav Res Ther 50:100–109
van der Wee NJ, van Veen JF, Stevens H et al (2008) Increased serotonin and dopamine transporter binding in psychotropic medication naive patients with generalized social anxiety disorder shown by 123I-beta-(4-iodophenyl)-tropane SPECT. J Nucl Med 49:757–763
van Houtem CM, Laine ML, Boomsma DI et al (2013) A review and meta-analysis of the heritability of specific phobia subtypes and corresponding fears. J Anxiety Disord 27:379–388
Webb BT, Guo AY, Maher BS et al (2012) Meta-analyses of genome-wide linkage scans of anxiety-related phenotypes. Eur J Hum Genet 20:1078–1084
Wells A, Welford M, King P et al (2010) A pilot randomized trial of metacognitive therapy vs applied relaxation in the treatment of adults with generalized anxiety disorder. Behav Res Ther 48:429–434
Wells A (2011) Metakognitive Therapie bei Angststörungen und Depression. Beltz, Weinheim
Yeganeh R, Beidel DC, Turner SM et al (2003) Clinical distinctions between selective mutism and social phobia: an investigation of childhood psychopathology. J Am Acad Child Adolesc Psychiatry 42:1069–1075
Ziegler C, Dannlowski U, Bräuer D et al (2015) Oxytocin receptor gene methylation: converging multilevel evidence for a role in social anxiety. Neuropsychopharmacology 40:1528–1538
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Plag, J., Ströhle, A. (2020). Angststörungen. In: Roth, G., Heinz, A., Walter, H. (eds) Psychoneurowissenschaften. Springer Spektrum, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-59038-6_13
Download citation
DOI: https://doi.org/10.1007/978-3-662-59038-6_13
Published:
Publisher Name: Springer Spektrum, Berlin, Heidelberg
Print ISBN: 978-3-662-59037-9
Online ISBN: 978-3-662-59038-6
eBook Packages: Life Science and Basic Disciplines (German Language)